News

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees.

On February 12

Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues:

• 
  Floating Rate Non-Cumulative Preferred Stock, Series A - $328.97 per

Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced that its Board of Directors has declared a quarterly cash dividend of $.28 per share

Enterprises in Switzerland increasingly are taking a cloud-native approach to managing data and workloads on public cloud infrastructure, and are demanding AIOps and FinOps capabilities from their

Schweizer Unternehmen wählen immer häufiger einen Cloud-nativen Ansatz, um Daten und Workloads in Public-Cloud-Infrastrukturen zu verarbeiten. Zudem fordern sie von ihren Dienstleistern die

The Board of Directors of Eastman Chemical Company (NYSE:EMN) has declared a quarterly cash dividend of $0.83 per share on the company's common stock.

The dividend is payable April 7, 2025, to

NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.40 per share on the Company’s outstanding Class A and Class B Common Stock payable on

NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.40 per share on the Company’s outstanding Class A and Class B Common Stock payable on

Cohu, Inc. (NASDAQ: COHU), a global supplier of equipment and services optimizing semiconductor manufacturing yield and productivity, today reported fiscal 2024 fourth quarter net sales of $94.1

JetBlue Airways Corporation (Nasdaq: JBLU) will participate in a fireside chat at the Barclays 42^nd Annual Industrial Select Conference on February 19^th, 2025 at approximately 7:30 a.m. ET.

A

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2024.

Fourth Quarter 2024 Financial Highlights:

• 
  Revenue grew 8%

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2024.

Fourth Quarter 2024 Financial Highlights:

• 
  Revenue grew 8%

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, February 27, 2025, following the release of its fourth

D.R. Horton, Inc. (NYSE:DHI), America’s Builder, announced that the Company will present to the investment community via webcast at the 2025 Barclays 42^nd Annual Industrial Select Conference on

D.R. Horton, Inc. (NYSE:DHI), America’s Builder, announced today that the Company will release financial results for its second quarter ended March 31, 2025 on Thursday, April 17, 2025 before the

VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that after 13 years with the Company, George E. Kilguss III

VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that after 13 years with the Company, George E. Kilguss III

VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that after 13 years with the Company, George E. Kilguss III

Humana and Monogram Health are pleased to announce a significant expansion, extending member access to in-home treatment for kidney disease and its underlying causes. Eligible Humana Medicare